Pharmacologic TWIK‐Related Acid‐Sensitive K+ Channel (TASK‐1) Potassium Channel Inhibitor A293 Facilitates Acute Cardioversion of Paroxysmal Atrial Fibrillation in a Porcine Large Animal Model
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacologic TWIK‐Related Acid‐Sensitive K+ Channel (TASK‐1) Potassium Channel Inhibitor A293 Facilitates Acute Cardioversion of Paroxysmal Atrial Fibrillation in a Porcine Large Animal Model
Authors
Keywords
-
Journal
Journal of the American Heart Association
Volume 9, Issue 10, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2020-05-09
DOI
10.1161/jaha.119.015751
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- N-glycosylation–dependent regulation of hK2P17.1 currents
- (2019) Felix Wiedmann et al. MOLECULAR BIOLOGY OF THE CELL
- Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K + Channel–Related Acid-Sensitive K + Channel-1) (K 2P 3.1) K + Channels Suppresses Atrial Fibrillation and Prevents Electrical Remodeling
- (2019) Constanze Schmidt et al. Circulation-Arrhythmia and Electrophysiology
- Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K2P) channels in murine disease models: focus on TASK-1
- (2018) Felix Wiedmann et al. BASIC RESEARCH IN CARDIOLOGY
- K2P2.1 (TREK-1)–activator complexes reveal a cryptic selectivity filter binding site
- (2017) Marco Lolicato et al. NATURE
- TASK-1 potassium channel is not critically involved in mediating hypoxic pulmonary vasoconstriction of murine intra-pulmonary arteries
- (2017) Ghulam Murtaza et al. PLoS One
- Letter by Olschewski et al Regarding Article, “Upregulation of K2P3.1 K+Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation”
- (2016) Andrea Olschewski et al. CIRCULATION
- Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial HypertensionCLINICAL PERSPECTIVE
- (2016) Fabrice Antigny et al. CIRCULATION
- Therapeutic targeting of two-pore-domain potassium (K2P) channels in the cardiovascular system
- (2016) F. Wiedmann et al. CLINICAL SCIENCE
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPACE
- Upregulation of K2P3.1 K+Current Causes Action Potential Shortening in Patients With Chronic Atrial FibrillationCLINICAL PERSPECTIVE
- (2015) Constanze Schmidt et al. CIRCULATION
- TASK-1 and TASK-3 may form heterodimers in human atrial cardiomyocytes
- (2015) Susanne Rinné et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment
- (2015) Larissa Fabritz et al. Nature Reviews Cardiology
- Cloning, functional characterization, and remodeling of K2P3.1 (TASK-1) potassium channels in a porcine model of atrial fibrillation and heart failure
- (2014) Constanze Schmidt et al. HEART RHYTHM
- SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information
- (2014) Marco Biasini et al. NUCLEIC ACIDS RESEARCH
- Role of K2P channels in stimulus-secretion coupling
- (2014) Donghee Kim et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Kv1.5 blockers preferentially inhibit TASK-1 channels: TASK-1 as a target against atrial fibrillation and obstructive sleep apnea?
- (2014) Aytug K. Kiper et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K+ (K2P) channels
- (2013) Constanze Schmidt et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A Novel Channelopathy in Pulmonary Arterial Hypertension
- (2013) Lijiang Ma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Benchmarking electrophysiological models of human atrial myocytes
- (2013) Mathias Wilhelms et al. Frontiers in Physiology
- Fully automated initiation of simulated episodes of atrial arrhythmias
- (2012) E. Matene et al. EUROPACE
- TASK-1 Channels May Modulate Action Potential Duration of Human Atrial Cardiomyocytes
- (2011) Sven H. Limberg et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Disruption of K 2P 6.1 Produces Vascular Dysfunction and Hypertension in Mice
- (2011) Eric E. Lloyd et al. HYPERTENSION
- Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: A historical perspective
- (2010) Nicolas Guex et al. ELECTROPHORESIS
- Novel pharmacological approaches for antiarrhythmic therapy
- (2010) Ursula Ravens NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- The SWISS-MODEL Repository and associated resources
- (2008) F. Kiefer et al. NUCLEIC ACIDS RESEARCH
- Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact
- (2008) Douglas A. Bayliss et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Solvers for the cardiac bidomain equations
- (2007) E.J. Vigmond et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now